XML 56 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Collaboration and License Agreements - Joint Venture and License Agreement with Visirna Therapeutics, Inc. (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Apr. 25, 2022
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Proceeds from the sale of future royalties       $ 250,000 $ 0  
Revenue   $ 146,267 $ 151,805 208,813 $ 179,244  
Deferred revenue   29,839   29,839   $ 74,099
Visirna Therapeutics, Inc. | Visirna License Agreement            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Revenue       900    
Contract assets   0   0    
Deferred revenue   $ 0   $ 0    
Visirna Therapeutics, Inc. | Visirna License Agreement | Variable Interest Entity, Primary Beneficiary            
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]            
Proceeds from the sale of future royalties $ 60,000